$219 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$30.35 - $42.20The lowest and highst price in the last 52 weeks.
22.74xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$1.52 (3.87%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$219 Billion|
|Enterprise Value||$246 Billion|
|Dividend Yield||$1.52 (3.87%)|
|1 Year Return||+10.9%|
|Outstanding Shares||5.58 Billion|
|Avg 30 Day Volume||32.4 Million|
|Earnings per Share||$1.71|
|Price to Sales Ratio||4.95|
|Price to Book Ratio||3.6|
|Revenue to Enterprise Value||5.06|
|EBIT to Enterprise Value||17.99|
|Total Debt to Enterprise Value||0.16|
|Debt to Equity||0.63|
|Gross Profit||$38.9 Billion|
|Net Income||$8.68 Billion|
|Quarterly Earnings Growth (YoY)||-71.4%|
|Return on Equity||13.73%|
|Return on Assets||5.63%|
|Return on Invested Capital||10.67%|
The government should consider requests of global drugmakers Pfizer and Moderna for indemnity protection to bring their Covid-19 vaccines into the country as mass vaccination is key in the fight ag...Economic Times India, 1 day ago
Hospitalizations and deaths should decline sharply if the vaccination program remains strong and mitigation efforts are followed. Latest COVID news.USA Today, 2 days ago
Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits. ...Benzinga, 5 days ago